| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.45 (Beat by $0.07) |
| EPS GAAP Actual | $0.45 (Beat by $0.07) |
| Revenue Actual | $0.168525B |
| Revenue Surprise | Beat by $168.525M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.2635 |
| EPS GAAP Estimate | $0.2635 |
| Revenue Estimate | $0.141561483B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 3.1 | 8.95 | 2.99917 | 3.24512 | 2 |
| Mar 2029 | 1.6 | 17.33 | 1.57436 | 1.62113 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.33 | 0.05975 | 0.168525B | 18.81% | 29.93M |
| FQ2 2025 (Jun 2025) | 0.28 | 0.28 | 0.145913B | 13.18% | 145.91M |
| FQ1 2025 (Mar 2025) | 0.33 | 0.33 | 0.138288B | 14.63% | 138.29M |
| FQ4 2024 (Dec 2024) | 0.4 | 0.4 | 0.168603B | 19.76% | 168.6M |
| FQ3 2024 (Sep 2024) | 0.24 | 0.24 | 0.136832B | 16.97% | 136.83M |
| FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 0.126676B | 14.37% | 126.68M |
| FQ4 2019 (Dec 2019) | 0.0723 | 0.0723 | 0.032426B | 100% | 32.43M |
| FQ1 2020 (Mar 2020) | 0.0449 | 0.0449 | 0.036354B | 100% | 36.35M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.2635
Consensus Revenue Estimates
0.141561483B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.47 | -- | 0.44905 | 0.47765 | 5 |
| FQ4 2027 (Dec 2027) | 0.55 | -- | 0.52548 | 0.55895 | 4 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 7 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 6 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 4 |
| FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 3 |
| FQ3 2026 (Jul 2026) | 0 | -INF | 0 | 0 | 4 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 4 |
| FQ1 2026 (Mar 2026) | 0.2635 | -25.24 | 0.25381 | 0.27601 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.19B | -- | 0.18B | 0.19B | 5 |
| FQ4 2027 (Dec 2027) | 0.22B | -- | 0.21B | 0.22B | 6 |
| FQ3 2027 (Sep 2027) | 0.19B | -- | 0.19B | 0.19B | 8 |
| FQ2 2027 (Jun 2027) | 0.16B | -- | 0.16B | 0.17B | 7 |
| FQ1 2027 (Mar 2027) | 0.14B | -- | 0.14B | 0.14B | 6 |
| FQ4 2026 (Oct 2026) | 0.14B | -- | 0.13B | 0.14B | 4 |
| FQ3 2026 (Jul 2026) | 0.13B | -25.19 | 0.13B | 0.14B | 4 |
| FQ2 2026 (Jun 2026) | 0.13B | -8.39 | 0.13B | 0.14B | 9 |
| FQ1 2026 (Mar 2026) | 0.14B | 2.31 | 0.14B | 0.15B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.27025 | 0.33 | 0.05975 | 18.11% |
| FQ2 2025 (Jun 2025) | 0.28 | 0.28 | 100% | |
| FQ1 2025 (Mar 2025) | 0.33 | 0.33 | 100% | |
| FQ4 2024 (Dec 2024) | 0.4 | 0.4 | 100% | |
| FQ3 2024 (Sep 2024) | 0.24 | 0.24 | 100% | |
| FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 100% | |
| FQ4 2019 (Dec 2019) | 0.0723 | 0.0723 | 100% | |
| FQ1 2020 (Mar 2020) | 0.0449 | 0.0449 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.14B | $0.17B | $29.93M | 17.76% |
| FQ2 2025 (Jun 2025) | $0B | $0.15B | $145.91M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.14B | $138.29M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.17B | $168.6M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.14B | $136.83M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.13B | $126.68M | 100% |
| FQ4 2019 (Dec 2019) | $0B | $0.03B | $32.43M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.04B | $36.35M | 100% |